HALOZYME THERAPEUTICS INC earnings per share and revenue

RV7 earnings per share for the last quarter are 1.14 EUR whereas the estimation was 0.89 EUR which accounts for 28.12% surprise. Company revenue for the same period amounts to 260.54 M EUR despite the estimated figure of 226.49 M EUR. Estimated earnings per share for the next quarter are 1.12 EUR, and revenue is expected to reach 278.57 M EUR. Also watch annual changes over time to get a bigger picture of RV7 earnings per share and revenue dynamics.